Table 2.
Logistic regression for 30-day mortality of FM.
| Variables | Univariable analysis | Model1 | Model2 | ||||
|---|---|---|---|---|---|---|---|
| OR (95%CI) | P Value | Adjusted OR (95%CI) | P Value | Adjusted OR (95%CI) | P Value | ||
| LT3S | 6.786(2.472, 18.629) | <0.001 | 3.409(1.019, 11.413) | 0.047 | |||
| FT3 | 0.272(0.139, 0.532) | <0.001 | 0.408(0.199, 0.837) | 0.014 | |||
| Age | 1.022(0.991, 1.055) | 0.166 | |||||
| Gender, male | 0.433(0.173, 1.084) | 0.074 | |||||
| VT/VF | 3.352(1.210, 9.288) | 0.020 | 1.442(0.397, 5.233) | 0.578 | 1.573(0.429, 5.771) | 0.495 | |
| SBP | 0.956(0.920, 0.994) | 0.022 | 0.964(0.917, 1.013) | 0.144 | 0.968(0.921, 1.017) | 0.198 | |
| HR | 1.016(1.001, 1.031) | 0.033 | 1.012(0.995, 1.030) | 0.179 | 1.011(0.993, 1.029) | 0.233 | |
| Creatine | 1.008(0.999, 1.016) | 0.057 | |||||
| Peak NT-proBNP* | 1.065(1.014, 1.119) | 0.012 | 0.993(0.929, 1.062) | 0.838 | 0.999(0.936, 1.067) | 0.987 | |
| Peak TnI | 1.038(1.007, 1.070) | 0.015 | 1.023(0.986, 1.061) | 0.231 | 1.022(0.984, 1.060) | 0.263 | |
| LVEF at admission | 0.902(0.840, 0.968) | 0.004 | 0.931(0.851, 1.018) | 0.117 | 0.931(0.850, 1.021) | 0.127 | |
| CRRT | 2.933(1.108, 7.768) | 0.030 | 1.732(0.460, 6.521) | 0.417 | 1.392(0.348, 5.561) | 0.640 | |
LT3S, low triiodothyronine syndrome; FT3, free triiodothyronine; VT, ventricular tachycardia; VF, ventricular fibrillation; SBP, systolic blood pressure; HR, heart rate; NT-proBNP, N-terminal pro-B-type natriuretic peptide; TnI, Troponin I; LVEF, left ventricular ejection fraction; CRRT, continuous renal replacement therapy.
Model1 includes LT3S and all significant variable at the univariate analysis. FT3 and all significant variable at the univariate analysis were included in Model 2.
* per 1000ng/L increase.